Carmine N. Stengone, Director: Kiora Pharmaceuticals KPRX Buy · Filed 24/09/12

Trade details

Type: Insider buy
Amount: $4,600
Shares · price: 1,250 sh · $3.68 a share
Held after: 1,250 sh
Stock: Kiora Pharmaceuticals KPRX
Person: Carmine N. StengoneDirector
Trade date: 24/09/11
Filed: 24/09/12
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 2 insiders

Kiora Pharmaceuticals trades, last 26 weeks

What else happened in Kiora Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/08/12~24/10/11

Carmine N. Stengone's recent trades

Carmine N. StengoneDirector, Officer
Planned sale10b5-1 planContineum Therapeutics
Planned sale10b5-1 plan
Contineum Therapeutics
CTNM
$41.8K
2,500 sh
$41.8K
Filed 09/08
Traded 09/08
Carmine N. StengoneDirector, Officer
Planned sale10b5-1 planContineum Therapeutics
Planned sale10b5-1 plan
Contineum Therapeutics
CTNM
$38.7K
2,500 sh
$38.7K
Filed 08/03
Traded 08/03
Carmine N. StengoneDirector, Officer
Planned sale10b5-1 planContineum Therapeutics
Planned sale10b5-1 plan
Contineum Therapeutics
CTNM
$36.4K
2,500 sh
$36.4K
Filed 07/08
Traded 07/08
Carmine N. StengoneDirector, Officer
Planned sale10b5-1 planContineum Therapeutics
Planned sale10b5-1 plan
Contineum Therapeutics
CTNM
$150K
10,000 sh
$150K
Filed 06/30
Traded 06/30
Carmine N. StengoneCEO and President
Sell10b5-1 planContineum Therapeutics
Sell10b5-1 plan
Contineum Therapeutics
CTNM
$70.5K
4,400 sh
$70.5K
Filed 02/26
Traded 02/24